Initial idea behind the technology, and clinical aims | To develop a catheter that can identify cardiac cells causing arrhythmia and neutralise them by delivering extremely cold temperatures
| To turn a predictive mathematical model into software that would improve obstetricians’ decisions during labour and delivery
| To develop a computerised system to enable clinicians to support chronically ill patients from a distance
|
Level of congruence, and key explanatory factors | High
▸ An international cadre of investigators conduct clinical studies, refine early versions of the catheter, and contribute to academic marketing around the world. ▸ Market approval is first obtained in Europe to generate sales as well as clinical data required for market approval in the USA. ▸ The procedure generates revenues for physicians, and marketing channels already exist.
| Medium
▸ Obstetricians are not eager to use the system, and established clinical practices seem hard to change. ▸ Although market approval is obtained in the USA, the development of new marketing channels is costly. ▸ Physician insurers become the key target as purchasers (offering reduced premiums to obstetricians who accept to use the system).
| Low
▸ The system is developed and evaluated in collaboration with a regional hospital. ▸ The co-design approach enables generating data on efficacy and responding to users’ requests, but it limits the growth of the venture. ▸ There is not a ‘single’ purchaser for a system that generates ‘distributed’ benefits (to patients, home care providers, hospitals).
|